Table 2 Demographic and clinical characteristics of the patients at baseline

Gender, Male, % (n)

Male

67% (6)

Age at baseline in years, Median [min; max]

37

44 [28; 48]

 Intravenous drug user

33% (3)

 Men who have sex with men (MSM)

MSM

22% (2)

 Heterosexual

44% (4)

Log ₁₀ of HIV viral load at baseline in copies per mL, Median [min; max]

5.5

5.4 [4.9; 6.4]

CD4 ⁺ /μL at baseline, Median [min; max]

20

25 [8; 97]

HAART regimen components

Patient 1:

(TDF + FTC) + DRVr

Patients 2–7:

(TDF + FTC) + EFV

Patients 8–9:

(ABC + 3TC) + EFV

2 nucleoside or nucleotide analogue reverse transcriptase inhibitors + 3^rd drug

(TDF + FTC) + DRVr